In particular, they measured the depth-dose distributions of oxygen ions beams at the HIT. Their work contributed to the development of a preclinical oxygen ion-beam experimental database, already being used in research purpose treatment planning systems to support radiobiological experiments with oxygen ion beams at HIT. [13] With respect to carbon ions, oxygen ions produce more nuclear fragments, which need to be investigated, as they can affect the RBE and the sensitivity to oxygenation. [14] In addition, the dose due to such fragments needs to be investigated not only in-field but also out-of-field, laterally and beyond the Bragg peak, to study the effect of the mixed radiation field in the healthy tissues surrounding the tumor target.
The possible use of helium and oxygen ions in hadron therapy has recently gained more attention. Yu-Shen et al. investigated the longitudinal and lateral dose profiles and RBE produced by protons, α particles, and carbon ions. [15] Tessonnier et al. studied the basic dosimetric features of the different ions, including oxygen ions by experiments. [16] Mattei et al. studied the prompt gamma-ray emission by the interaction of helium, carbon, and oxygen ion beams with a polymethyl methacrylate phantom. [17] Burigo et al. compared the dose distributions and cell survival fractions for various incident ions. They concluded that the optimal projectile depends on the location of the tumor and on the radiosensitivity of the irradiated tissues. [18] This work compares the dose produced in a water phantom by an oxygen ion ( 16 O) beam with respect to a carbon ( 12 C) ion beam. This work has been done by using Geant4 Monte Carlo simulations. [19] 
MaterIals and Methods
Geant4 Monte Carlo simulation toolkit, from the European Organization for Nuclear Research, CERN (Geneva, Switzerland) version 4.10.1.p01 was used to model and compare the radiation fields produced by carbon and oxygen ion beams in a 30 cm × 30 cm × 30 cm water phantom. A 5 cm × 5 cm square beam is simulated normally incident on the water phantom with an air gap of 30 cm between the particle source and the surface of the phantom. Carbon beams were generated with energies of 162 MeV/u and 290 MeV/u, which are typical energies used in carbon ion therapy at HIMAC. [20] The simulations were repeated substituting the carbon with an oxygen beam with energies 192 MeV/u and 345 MeV/u (corresponding to ranges of approximately 60 mm and 161 mm in water, similar to the carbon ion beam).
The G4EmStandardPhysics_Option3 and QGSP_BIC_EMY Geant4 Physics List were adopted to model the electromagnetic and hadronic physics interactions. [21] The results obtained with oxygen and carbon ion beams were compared in terms of dose distribution in the phantom and peak to entrance dose ratio. The contribution to dose deriving from secondary fragments was studied as well. 10 6 histories were simulated for each configuration to obtain a statistical uncertainty within 1%, with the corresponding confidence interval of the uncertainty being 95%. Figure 1 shows the energy deposited in the phantom per incident particle in the case of incident 162 MeV/u 12 C and 192 MeV/u 16 O ions. The 16 O beam produces approximately 50% higher energy deposition than the 12 C beam at the entrance, at 2 mm depth from the surface of the phantom. At the Bragg peak, approximately at 60-mm depth from the surface of the phantom, the 16 O beam produces approximately 60% higher energy deposition than the 12 C beam. In addition, the 16 O beam produces 150% higher energy deposition tail just after the Bragg peak (at 2-mm depth after the Bragg peak). The peak-to-entrance ratio is 9.0 for the 16 O, just slightly higher than that of 12 C beams, which is 8.5. Figure 2 shows the energy deposition per incident particle, for 12 C and 16 O beams with energies 290 MeV/u and 345 MeV/u, respectively. In this case, it was found that the dose at the entrance (at 2-mm depth from the surface of the phantom) and at the Bragg peak (approximately at 60-mm depth), produced by the 16 O ions was about 60% higher than in the case of the 12 C beam. Still, the dose at the distal edge of the Bragg peak (2 mm after the Bragg peak) is 140% higher in the case of irradiation with oxygen beams. This is a shortcoming of oxygen ions (organs at risk may be located at the distal edge) and should be taken into consideration if switching from carbon ions to oxygen ions in hadron therapy. The peak-to-entrance ratio for 16 O and 12 C beams is found to be 5.4 and 5.8, respectively
results and dIscussIon
These results are in agreement with Francesco et al., who compared absolute dose per unit fluence produced by four different types of ion species (protons and helium, carbon and oxygen ions). [12] Higher peak-to-entrance ratio means that the dose may be increased in the tumor target or reduced in the surrounding healthy tissues of the patient, in front of the tumor. Results of the current study show that increasing the beam energy decreases the peak-to-entrance ratio for both oxygen and carbon ions. In terms of peak-to-entrance The results clearly illustrate that fragmentation has a more prominent role in the case of the oxygen beam, as expected, in all regions (i.e., the plateau region, the Bragg peak position, and beyond the Bragg peak). The dose contribution of individual secondary fragment species with higher production yield is presented in Figure 4 . Both hydrogen and helium fragments have a longer range than incident ions and heavier fragments, and they contribute most to the dose beyond the Bragg peak.
It can be observed that secondary protons, produced by incident oxygen ion beams deposit more energy than in the case of carbon ions beams in all regions (i.e., the plateau region, the Bragg peak position, and beyond the Bragg peak position). The contribution to the energy deposition deriving from secondary alpha particles is similar along the Bragg peak when comparing oxygen and carbon ion beams. After the Bragg peak, in the case of oxygen ions, alpha particles deposit more energy.
In the case of carbon ion beams, secondary lithium (Li), beryllium (Be), and boron (B) fragments produce more dose in the plateau region and at the Bragg peak position compared to oxygen ions, but, after the Bragg peak, the dose contribution of such fragments is higher with incident oxygen ions. The energy deposition contribution of secondary nitrogen (N) fragments produced by primary oxygen ions is dominant everywhere along the Bragg peak.
Lateral dose distributions for several selected secondary fragments produced by incident oxygen and carbon ions have been compared. Figure 5 shows the results for protons (P) and helium (He), lithium (Li) and boron (B) ion fragments produced by incident 162 MeV/u 12 C and 192 MeV/u 16 O ions. The two-dimensional histogram (normalized per incident primary particle) shows the effects of the scattering outside the radiation field. As expected, the secondary protons scatter more with respect to the other fragments because of their smaller mass. Therefore, lighter fragments contribute more to energy deposition out-of-field. With an increase in the mass of the fragment, the energy is deposited more in a forward direction. The energy deposition of secondary protons is broader out-of-field with respect to other fragments because protons scatter more due to their smaller mass. Furthermore, the secondary proton beam generated by 16 O is slightly broader than 12 C at the position 60 mm and 62 mm. The relative energy deposition for 16 O is higher than 12 C. With an increase of mass, the heavier fragments scatter less and mostly in the forward direction of the incident beam. In the case of secondary Li-ions, the lateral dose distribution for both oxygen and carbon ion are also similar at plateau, at Bragg peak and beyond the Bragg peak. The relative energy deposition for 16 O is also higher than 12 C.
conclusIons
This work compared the energy deposition in a water phantom, produced by oxygen ions, proposed as alternative to carbon ions for hadron therapy. The results show that oxygen beams are characterized by a higher dose per incident ion and a slightly bigger peak-to-entrance ratio with respect to clinical carbon-ion beams.
With respect to carbon ions, oxygen beams are characterized by higher production of nuclear fragments, which deposit energy beyond the Bragg peak and out-of-field. In addition, such nuclear fragments have an impact on the RBE. These factors have to be carefully taken into account when considering oxygen ions as a possible alternative to carbon therapy. This work confirms the results of Kumar et al., who investigated various types of ion species using simulation methods and concluded that oxygen ions are the most suitable heavy ions for hadron therapy in addition to carbon ions due to a higher peak-to-entrance ratio and higher energy deposition at the Bragg peak, even though it has a slightly higher entrance dose compared to carbon ion beams. [22] In the study of the dependence of the RBE on LET by Francesco et al. using research treatment planning system, the results show the RBE of oxygen was 1.68 and 2.83 at the entrance and at the Bragg peak, respectively and the RBE of carbon was 1.44 and 2.61 at the entrance and at the Bragg peak, respectively. The RBE of oxygen ions is slightly higher than carbon ions at the entrance and at the Bragg peak. [12] This may be due to the fact that oxygen ions, carrying higher charge, have comparatively higher LET than carbon ions and hence deposit higher dose from fragmentations, translating into higher RBE for oxygen ions than that for carbon ions. Therefore, oxygen beams may be more efficient than carbon ions with hypoxic tumors. [10] [11] [12] Usually, LET is a key parameter to explain the biological effects induced by charged particles. However, the LET depth-dose profile is also influenced by the types of ions, and hence LET alone cannot explain the differences in their clinical properties. The RBE depends on many parameters, such as LET, fractionation, oxygenation, cell cycle, and endpoint. This study focused on the physical properties of carbon and oxygen ion beams, but biological aspects should be considered as well so that the choice of the optimal ion depends on the specific tumor configuration. [23, 24] Future experimental works will be carried out at the HIMAC, NIRS. Other ions lighter than carbon ions will be studied, especially helium, as helium nuclei are expected to have favorable dose distributions and a high potential for application in hadron therapy. [25, 26] 
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